US$ 27.57
bpc 157 prodaja BPC-157 (10mg vials) BPC-157 | Research Grade Peptide
Description
It works through a different mechanism than GHK-Cu: PDRN activates the A2A adenosine receptor, which triggers tissue regeneration, dampens inflammation, and supports the cellular metabolism of dermal cells

Barbara Hribar-Lee studied chemistry at University of Ljubljana, Slovenia

The FDA does not review or approve any compounded medications for safety or effectiveness

Its smaller molecular weight allows deeper dermal penetration compared to AHK-Cu peptides
